United States Anticoagulants Market Report 2017

December 2017 | 106 pages | ID: UC19C7DC7B5EN
QYResearch

Abstracts

In this report, the United States Anticoagulants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Anticoagulants in these regions, from 2012 to 2022 (forecast).

United States Anticoagulants market competition by top manufacturers/players, with Anticoagulants sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi
• Bayer
• Boehringer Ingelheim
• Johnson & Johnson
• Genentech (Roche)
• AstraZeneca
• Bristol-Myers Squibb
• Aspen
• Lilly
• Otsuka
• Pfizer
• Daiichi Sankyo
• The Medicines Company

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Platelet aggregation inhibitors (PAI)
• Low-molecular-weight Heparin (LMWH)
• Direct thrombin inhibitor (DTI)
• Direct factor Xa inhibitors (DFXa)
• Vitamin K antagonists (VKA)
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• VTE
• ACS/MI
• AF
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Anticoagulants Market Report 2017

1 ANTICOAGULANTS OVERVIEW

1.1 Product Overview and Scope of Anticoagulants
1.2 Classification of Anticoagulants by Product Category
  1.2.1 United States Anticoagulants Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Anticoagulants Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Platelet aggregation inhibitors (PAI)
  1.2.4 Low-molecular-weight Heparin (LMWH)
  1.2.5 Direct thrombin inhibitor (DTI)
  1.2.6 Direct factor Xa inhibitors (DFXa)
  1.2.7 Vitamin K antagonists (VKA)
  1.2.8 Others
1.3 United States Anticoagulants Market by Application/End Users
  1.3.1 United States Anticoagulants Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 VTE
  1.3.3 ACS/MI
  1.3.4 AF
  1.3.5 Other
1.4 United States Anticoagulants Market by Region
  1.4.1 United States Anticoagulants Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Anticoagulants Status and Prospect (2012-2022)
  1.4.3 Southwest Anticoagulants Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Anticoagulants Status and Prospect (2012-2022)
  1.4.5 New England Anticoagulants Status and Prospect (2012-2022)
  1.4.6 The South Anticoagulants Status and Prospect (2012-2022)
  1.4.7 The Midwest Anticoagulants Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Anticoagulants (2012-2022)
  1.5.1 United States Anticoagulants Sales and Growth Rate (2012-2022)
  1.5.2 United States Anticoagulants Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTICOAGULANTS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Anticoagulants Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Anticoagulants Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Anticoagulants Average Price by Players/Suppliers (2012-2017)
2.4 United States Anticoagulants Market Competitive Situation and Trends
  2.4.1 United States Anticoagulants Market Concentration Rate
  2.4.2 United States Anticoagulants Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anticoagulants Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTICOAGULANTS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Anticoagulants Sales and Market Share by Region (2012-2017)
3.2 United States Anticoagulants Revenue and Market Share by Region (2012-2017)
3.3 United States Anticoagulants Price by Region (2012-2017)

4 UNITED STATES ANTICOAGULANTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Anticoagulants Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Anticoagulants Revenue and Market Share by Type (2012-2017)
4.3 United States Anticoagulants Price by Type (2012-2017)
4.4 United States Anticoagulants Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTICOAGULANTS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Anticoagulants Sales and Market Share by Application (2012-2017)
5.2 United States Anticoagulants Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTICOAGULANTS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anticoagulants Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.2 Anticoagulants Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim
  6.3.2 Anticoagulants Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Boehringer Ingelheim Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.2 Anticoagulants Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Genentech (Roche)
  6.5.2 Anticoagulants Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Genentech (Roche) Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.2 Anticoagulants Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bristol-Myers Squibb
  6.7.2 Anticoagulants Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bristol-Myers Squibb Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Aspen
  6.8.2 Anticoagulants Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Aspen Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Lilly
  6.9.2 Anticoagulants Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Lilly Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Otsuka
  6.10.2 Anticoagulants Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Otsuka Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Pfizer
6.12 Daiichi Sankyo
6.13 The Medicines Company

7 ANTICOAGULANTS MANUFACTURING COST ANALYSIS

7.1 Anticoagulants Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anticoagulants

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anticoagulants Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anticoagulants Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTICOAGULANTS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Anticoagulants Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Anticoagulants Sales Volume Forecast by Type (2017-2022)
11.3 United States Anticoagulants Sales Volume Forecast by Application (2017-2022)
11.4 United States Anticoagulants Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Anticoagulants
Figure United States Anticoagulants Market Size (Units) by Type (2012-2022)
Figure United States Anticoagulants Sales Volume Market Share by Type (Product Category) in 2016
Figure Platelet aggregation inhibitors (PAI) Product Picture
Figure Low-molecular-weight Heparin (LMWH) Product Picture
Figure Direct thrombin inhibitor (DTI) Product Picture
Figure Direct factor Xa inhibitors (DFXa) Product Picture
Figure Vitamin K antagonists (VKA) Product Picture
Figure Others Product Picture
Figure United States Anticoagulants Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Anticoagulants by Application in 2016
Figure VTE Examples
Table Key Downstream Customer in VTE
Figure ACS/MI Examples
Table Key Downstream Customer in ACS/MI
Figure AF Examples
Table Key Downstream Customer in AF
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Anticoagulants Market Size (Million USD) by Region (2012-2022)
Figure The West Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anticoagulants Sales (Units) and Growth Rate (2012-2022)
Figure United States Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anticoagulants Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Anticoagulants Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Anticoagulants Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anticoagulants Sales Share by Players/Suppliers
Figure 2017 United States Anticoagulants Sales Share by Players/Suppliers
Figure United States Anticoagulants Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Anticoagulants Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Anticoagulants Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anticoagulants Revenue Share by Players/Suppliers
Figure 2017 United States Anticoagulants Revenue Share by Players/Suppliers
Table United States Market Anticoagulants Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Anticoagulants Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Anticoagulants Market Share of Top 3 Players/Suppliers
Figure United States Anticoagulants Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anticoagulants Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anticoagulants Product Category
Table United States Anticoagulants Sales (Units) by Region (2012-2017)
Table United States Anticoagulants Sales Share by Region (2012-2017)
Figure United States Anticoagulants Sales Share by Region (2012-2017)
Figure United States Anticoagulants Sales Market Share by Region in 2016
Table United States Anticoagulants Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Anticoagulants Revenue Share by Region (2012-2017)
Figure United States Anticoagulants Revenue Market Share by Region (2012-2017)
Figure United States Anticoagulants Revenue Market Share by Region in 2016
Table United States Anticoagulants Price (K USD/Unit) by Region (2012-2017)
Table United States Anticoagulants Sales (Units) by Type (2012-2017)
Table United States Anticoagulants Sales Share by Type (2012-2017)
Figure United States Anticoagulants Sales Share by Type (2012-2017)
Figure United States Anticoagulants Sales Market Share by Type in 2016
Table United States Anticoagulants Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Anticoagulants Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anticoagulants by Type (2012-2017)
Figure Revenue Market Share of Anticoagulants by Type in 2016
Table United States Anticoagulants Price (K USD/Unit) by Types (2012-2017)
Figure United States Anticoagulants Sales Growth Rate by Type (2012-2017)
Table United States Anticoagulants Sales (Units) by Application (2012-2017)
Table United States Anticoagulants Sales Market Share by Application (2012-2017)
Figure United States Anticoagulants Sales Market Share by Application (2012-2017)
Figure United States Anticoagulants Sales Market Share by Application in 2016
Table United States Anticoagulants Sales Growth Rate by Application (2012-2017)
Figure United States Anticoagulants Sales Growth Rate by Application (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Anticoagulants Sales Growth Rate (2012-2017)
Figure Sanofi Anticoagulants Sales Market Share in United States (2012-2017)
Figure Sanofi Anticoagulants Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Anticoagulants Sales Growth Rate (2012-2017)
Figure Bayer Anticoagulants Sales Market Share in United States (2012-2017)
Figure Bayer Anticoagulants Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Anticoagulants Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Anticoagulants Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Anticoagulants Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Anticoagulants Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Anticoagulants Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Anticoagulants Revenue Market Share in United States (2012-2017)
Table Genentech (Roche) Basic Information List
Table Genentech (Roche) Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Genentech (Roche) Anticoagulants Sales Growth Rate (2012-2017)
Figure Genentech (Roche) Anticoagulants Sales Market Share in United States (2012-2017)
Figure Genentech (Roche) Anticoagulants Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Anticoagulants Sales Growth Rate (2012-2017)
Figure AstraZeneca Anticoagulants Sales Market Share in United States (2012-2017)
Figure AstraZeneca Anticoagulants Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Anticoagulants Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Anticoagulants Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Anticoagulants Revenue Market Share in United States (2012-2017)
Table Aspen Basic Information List
Table Aspen Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Aspen Anticoagulants Sales Growth Rate (2012-2017)
Figure Aspen Anticoagulants Sales Market Share in United States (2012-2017)
Figure Aspen Anticoagulants Revenue Market Share in United States (2012-2017)
Table Lilly Basic Information List
Table Lilly Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Lilly Anticoagulants Sales Growth Rate (2012-2017)
Figure Lilly Anticoagulants Sales Market Share in United States (2012-2017)
Figure Lilly Anticoagulants Revenue Market Share in United States (2012-2017)
Table Otsuka Basic Information List
Table Otsuka Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Otsuka Anticoagulants Sales Growth Rate (2012-2017)
Figure Otsuka Anticoagulants Sales Market Share in United States (2012-2017)
Figure Otsuka Anticoagulants Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Daiichi Sankyo Basic Information List
Table The Medicines Company Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anticoagulants
Figure Manufacturing Process Analysis of Anticoagulants
Figure Anticoagulants Industrial Chain Analysis
Table Raw Materials Sources of Anticoagulants Major Players/Suppliers in 2016
Table Major Buyers of Anticoagulants
Table Distributors/Traders List
Figure United States Anticoagulants Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Anticoagulants Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Anticoagulants Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Anticoagulants Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Anticoagulants Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Anticoagulants Sales Volume (Units) Forecast by Type in 2022
Table United States Anticoagulants Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Anticoagulants Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Anticoagulants Sales Volume (Units) Forecast by Application in 2022
Table United States Anticoagulants Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Anticoagulants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anticoagulants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anticoagulants Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources